Drug development: Longer-lived proteins

Nature. 2010 Oct 28;467(7319):1051-2. doi: 10.1038/4671051a.
No abstract available

Publication types

  • News

MeSH terms

  • Animals
  • Drug Design*
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / chemistry
  • Interferon-alpha / pharmacokinetics
  • Mice
  • Neoplasms / blood supply
  • Neoplasms / drug therapy*
  • Neoplasms / metabolism*
  • Polyethylene Glycols / chemistry
  • Polyethylene Glycols / pharmacokinetics
  • Polymers / chemical synthesis
  • Polymers / chemistry*
  • Polymers / pharmacokinetics
  • Polymers / therapeutic use
  • Protein Engineering / methods*
  • Recombinant Proteins / chemical synthesis*
  • Recombinant Proteins / pharmacokinetics*
  • Recombinant Proteins / therapeutic use

Substances

  • Interferon alpha-2
  • Interferon-alpha
  • Polymers
  • Recombinant Proteins
  • Polyethylene Glycols
  • peginterferon alfa-2a